Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
3C Study in Kidney Transplantation
NCT01120028Phase 3Completed
- Sponsor
- University of Oxford
- Start
- Sep 2010
- Primary completion
- Feb 2014
- Modality
- Nanoparticles, Monoclonal Antibodies, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of alemtuzumab, nab-sirolimus in kidney transplantation, sponsored by University of Oxford. Started Sep 2010; status: completed.
02
Drugs
alemtuzumabnab-sirolimus
03
Conditions
kidney transplantation
Beyond the preview
Go deeper on NCT01120028.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01120028.